东宝生物
(300239)
| 流通市值：28.96亿 | | | 总市值：29.15亿 |
| 流通股本：5.90亿 | | | 总股本：5.94亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 453,400,915.3 | 458,680,096.3 | 482,384,068.33 | 483,228,383.16 |
| 应收票据及应收账款 | 260,713,012.96 | 229,157,666.35 | 227,852,958.86 | 215,954,567.78 |
| 其中：应收票据 | 54,011,099.67 | 50,050,763.99 | 47,235,470.06 | 42,858,534.82 |
| 应收账款 | 206,701,913.29 | 179,106,902.36 | 180,617,488.8 | 173,096,032.96 |
| 应收款项融资 | 34,165,370.61 | 17,812,253.77 | 24,994,981.45 | 24,582,055.02 |
| 预付款项 | 7,701,018.57 | 9,427,842.32 | 7,373,451.65 | 8,998,788.15 |
| 其他应收款合计 | 1,057,758.37 | 1,041,875.98 | 1,022,315.09 | 1,232,894.17 |
| 存货 | 398,195,306.23 | 415,847,348.52 | 401,367,848.15 | 420,415,267.14 |
| 合同资产 | - | - | 0 | - |
| 其他流动资产 | 922,057.09 | 2,141,887.63 | 3,461,923.41 | 3,399,955.84 |
| 流动资产合计 | 1,156,155,439.13 | 1,134,108,970.87 | 1,148,457,546.94 | 1,157,811,911.26 |
| 非流动资产: | | | | |
| 长期股权投资 | 12,317,121.27 | 12,878,127.4 | 13,501,581.85 | 13,914,675.17 |
| 其他权益工具投资 | 5,621,494.45 | 5,621,494.45 | 5,621,494.45 | 5,621,494.45 |
| 投资性房地产 | 4,115,586.83 | 4,308,661.72 | 4,501,736.62 | 4,694,811.51 |
| 固定资产 | 1,171,430,476.87 | 1,025,368,608.98 | 1,044,385,681.18 | 1,026,735,802.29 |
| 在建工程 | 78,267,958.75 | 188,423,550.94 | 150,855,639.19 | 154,670,083.66 |
| 无形资产 | 132,423,526.21 | 133,927,642.89 | 135,787,850.22 | 137,647,929.21 |
| 长期待摊费用 | 3,206,171.45 | 3,086,974.33 | 3,259,974.55 | 2,386,461.97 |
| 递延所得税资产 | 19,612,006.73 | 19,023,305.52 | 18,195,681.53 | 15,335,688.83 |
| 其他非流动资产 | 43,317,981.01 | 47,219,982.62 | 25,118,797.75 | 25,021,233.13 |
| 非流动资产合计 | 1,470,312,323.57 | 1,439,858,348.85 | 1,401,228,437.34 | 1,386,028,180.22 |
| 资产总计 | 2,626,467,762.7 | 2,573,967,319.72 | 2,549,685,984.28 | 2,543,840,091.48 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 191,185,811.61 | 151,873,797.67 | 152,181,188.01 | 163,992,478.39 |
| 其中：应付票据 | 101,511,400 | 67,831,400 | 58,900,000 | 83,852,800 |
| 应付账款 | 89,674,411.61 | 84,042,397.67 | 93,281,188.01 | 80,139,678.39 |
| 合同负债 | 8,293,757.76 | 4,932,711.15 | 7,514,727.06 | 8,192,670.37 |
| 应付职工薪酬 | 13,054,624.01 | 14,146,859.79 | 14,681,459.11 | 11,301,493.88 |
| 应交税费 | 7,798,624.91 | 12,499,511.41 | 5,812,861.21 | 7,903,993.03 |
| 其他应付款合计 | 12,586,258.56 | 10,733,264.82 | 11,024,894.25 | 12,153,176.51 |
| 一年内到期的非流动负债 | 8,738,027.92 | 7,608,277.45 | 6,486,441.01 | 5,338,823.34 |
| 其他流动负债 | 32,631,953.37 | 33,915,773.63 | 38,150,976.04 | 27,265,214.55 |
| 流动负债合计 | 274,289,058.14 | 235,710,195.92 | 235,852,546.69 | 236,147,850.07 |
| 非流动负债: | | | | |
| 长期借款 | 38,260,000 | 40,530,000 | 40,530,000 | 43,300,000 |
| 应付债券 | 461,384,625.35 | 457,310,820.96 | 453,170,136.46 | 449,101,760.96 |
| 长期应付款 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 递延收益 | 53,092,586.61 | 50,447,112.83 | 50,247,612.79 | 51,881,591.81 |
| 递延所得税负债 | 35,736,696.38 | 37,080,284 | 36,690,855.54 | 36,218,333.59 |
| 非流动负债合计 | 598,473,908.34 | 595,368,217.79 | 590,638,604.79 | 590,501,686.36 |
| 负债合计 | 872,762,966.48 | 831,078,413.71 | 826,491,151.48 | 826,649,536.43 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 593,623,165 | 593,607,933 | 593,607,933 | 593,607,933 |
| 其他权益工具 | 25,092,925.56 | 25,098,497.28 | 25,098,497.28 | 25,098,497.28 |
| 资本公积 | 644,474,141.01 | 644,381,265.12 | 644,381,265.12 | 644,381,265.12 |
| 减:库存股 | 56,114,846.36 | 56,114,846.36 | 56,114,846.36 | 56,110,096 |
| 盈余公积 | 67,307,051 | 67,307,051 | 67,307,051 | 65,046,867.91 |
| 未分配利润 | 479,322,360.01 | 468,609,005.97 | 448,914,932.76 | 445,287,346.99 |
| 归属于母公司股东权益合计 | 1,753,704,796.22 | 1,742,888,906.01 | 1,723,194,832.8 | 1,717,311,814.3 |
| 少数股东权益 | - | - | - | -121,259.25 |
| 股东权益合计 | 1,753,704,796.22 | 1,742,888,906.01 | 1,723,194,832.8 | 1,717,190,555.05 |
| 负债和股东权益合计 | 2,626,467,762.7 | 2,573,967,319.72 | 2,549,685,984.28 | 2,543,840,091.48 |
| 公告日期 | 2026-08-24 | 2026-04-24 | 2026-03-30 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |